Ami Bavishi | Director of Investor Relations |
Vince Anido | Chairman & Chief Executive Officer |
Tom Mitro | President & Chief Operating Officer |
Rich Rubino | Chief Financial Officer |
David Hollander | Chief Research & Development Officer |
Casey Kopczynski | Chief Scientific Officer |
Annabel Samimy | Stifel |
Ken Cacciatore | Cowen & Company |
Serge Belanger | Needham & Company |
Dana Flanders | Guggenheim & Partners |
Greg Fraser | Truist Securities |
Francois Brisebois | Oppenheimer |
Elliot Wilbur | Raymond James |
Dan Clark | Mizuho |
Good afternoon and thank you for standing by and welcome to the Aerie Pharmaceuticals Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. Today's conference call is being recorded. It is now my pleasure to turn the floor over to Aerie's Director of Investor Relations, Ami Bavishi.